Abstract
Epidemiological findings indicate that hormonal influences may play a role in the etiology of renal cell cancer (RCC). The possible effect of childbearing remains enigmatic; while some investigators have reported a positive association between number of births and renal cell cancer risk, others have not. A case–control study, nested within a nation-wide Fertility Register covering Swedish women born 1925 and later, was undertaken to explore possible associations between parity and age at first birth and the risk of renal cell cancer. Among these women a total of 1465 cases of RCC were identified in the Swedish Cancer Register between 1958 and 1992 and information on the number of live childbirths and age at each birth was obtained by linkage to the Fertility Database. For each case, five age-matched controls were randomly selected from the same register. Compared to nulliparous women, ever-parous women were at a 40% increased risk of RCC (Odds Ratio [OR]=1.42; 95% CI 1.19-1.69). The corresponding OR for women of high parity (five or more live births) was 1.91 (95% CI 1.40–2.62). After controlling for age at first birth among parous women, each additional birth was associated with a 15% increase in risk (OR=1.15; 95% CI 1.08–1.22). The observed positive association between parity and renal cell cancer risk is unlikely to be fully explained by uncontrolled confounding, but warrants further evaluation in large studies, with allowance for body mass index.
Similar content being viewed by others
Main
Cancer of the renal parenchyma, or renal cell cancer (RCC), represents about 80% of all kidney cancer cases in Sweden and is about twice as common in men than among women. Incidence rates in Sweden have tended to decrease among both men and women (Swedish Cancer Registry, 2000), during the past two decades in contrast to many other areas in the world. Reported international incidence rates vary more than 10-fold, with the highest rates found in northern, western and eastern Europe, Australia and North America (Ferlay et al, 2001). Apart from cigarette smoking and obesity, and possibly weight cycling, hypertension and/or antihypertensive medication, the causes of renal cell cancer are unclear (McLaughlin and Lipworth, 2000).
Experimental findings of oestrogen-induced renal cell carcinogenesis in animals (Li and Li, 1990) have prompted an interest in the possible influence of hormonal factors in humans. Weak positive associations have been reported for use of oral contraceptives (McLaughlin et al, 1992) and replacement oestrogens in some (Asal et al, 1988; McLaughlin et al, 1992), but not all studies (McLaughlin et al, 1984; Adami et al, 1998). A large case–control study, however, found a reduced risk of renal cell cancer following oral contraceptive use (Lindblad et al, 1995), although another recent study found no relationship (Gago-Dominguez et al, 1999). Two studies showed no relation between hysterectomy or oophorectomy and risk of RCC (Wynder et al, 1974; McLaughlin et al, 1984), whereas other investigators have reported an increased risk following hysterectomy (McCredie and Stewart, 1992; Mellemgaard et al, 1994; Gago-Dominguez et al, 1999) and both hysterectomy and oophorectomy (Lindblad et al, 1995). There is also some epidemiological evidence that childbearing may play a role in the development of RCC (Kreiger et al, 1993; Chow et al, 1995; Lindblad et al, 1995).
To further examine this issue, we utilised a large population-based data set to explore possible associations between pregnancy and the risk of renal cell cancer among Swedish women.
Materials and methods
We merged data from two population-based Swedish registers, the Fertility Register and the Cancer Register, both updated through 1992, through a unique national registration number.
The Fertility Register was originally based on women born between 1925 and 1960 who were resident citizens of Sweden in 1960. For these women, reproductive data (nulliparity, number and dates of live births) during the period 1943–1960 were collected retrospectively at the 1960 Census. Later birth cohorts of all Swedish women have been added continuously, with the women's births being recorded annually via vital statistics records. For the present study, the Fertility Register included almost 3.4 million live births recorded from 1943 to 1992 among approximately 2.4 million women born between 1925 and 1972. Based on a nation-wide reporting system of all births to women residing in Sweden, the quality of data concerning number and dates of birth is generally high (Johansson and Finnäs, 1983). In the oldest cohorts, mainly women born 1925–29, fertility may be underestimated since children born before 1943, those not living with their mothers, and those who died before the 1960 Census, were not recorded. There might also be a slight overestimation of fertility between 1943 and 1960 because adopted and foster children were included in the retrospectively collected information. From 1961 and onwards, only biological children were included. Dates of death and emigration among registered women are recorded yearly in the Fertility Register. Because women with 10 or more births are rare in the birth cohorts under study, complete birth dates were only obtained for up to nine children per woman for the purpose of this study. Subjects with 10 or more births were identifiable by a two-digit parity code.
The Swedish Cancer Register started in 1958. All newly diagnosed malignant tumours must be reported to the Register separately by both the clinician and the pathologist or cytologist. Nearly 100% of all diagnosed cancers are recorded (Swedish Cancer Registry, 2000). Among resident Swedish women born between 1925 and 1972, a total of 2086 cases of kidney cancer (International Classification of Diseases (ICD)-7 : 180) were recorded in the Cancer Register from January 1, 1958 to December 31, 1992. Of these, 1856 (88.9 %) were identified in the Fertility Register. Thus, no match was achieved for 230 cases recorded in the Cancer Register, some of which represent mismatches due to aberrant national registration numbers, while the majority are non-Swedish citizens who are recorded only in the Cancer Register. We excluded 14 cases diagnosed in 1958–1960 who were survivors with prevalent cancers at the time of the 1960 Census, two cases with more than nine children, 193 cases with non-renal cell cancer and 368 cases with histopathological-codes other than adenocarcinoma (code: 096). Because of overlap between the excluded groups, the final analysis encompassed 1465 cases of renal cell cancer with concomitant fertility information.
A nested case–control study was undertaken to evaluate possible associations between the recorded reproductive variables and RCC. For every case, five comparison women (controls) matched on year and month of birth were randomly selected among those in the Fertility Register. The controls had to be alive at the date of the diagnosis of the case and be residents of Sweden, without themselves having been diagnosed with kidney cancer. Controls were assigned an index date that was the same as the diagnosis date of their matched case. For both cases and controls, only pregnancies before the date of the diagnosis of the case (the index date for the control) were included in the analysis. Controls with more than nine births were excluded, leaving five case–control sets being matched 1:4.
Statistical analysis
The statistical analyses used matched conditional logistic regression (Breslow and Day, 1980). Associations between the reproductive risk factors and RCC were measured using odds ratios (OR) as estimates of relative risks (Rothman and Greenland, 1998), and their 95% confidence intervals (CI). Age at first birth was analysed both as a categorical variable (nulliparous, <20, 20–24, 25–29, 30+) and as a continuous variable in the analysis for parous women. Risk estimates with time since most recent pregnancy were calculated among uniparous, biparous and triparous women, compared to nulliparous women.
Results
More than half of all renal cell cancers (59.9%) in women were diagnosed at age 50 or over (Table 1), with a mean age at diagnosis of 50.4 years. We found a strong positive association between number of births and risk of RCC (Table 2). Compared to nulliparous women, ever parous women were at a 40% increased risk of RCC (OR=1.42; 95% CI=1.19–1.69). The corresponding OR for women of high parity (five or more live births) was 1.91 (95% CI=1.40–2.62). After controlling for age at first birth among parous women, risk increased monotonically and each additional birth was associated with a 15% increase in risk (OR=1.15; 95% CI=1.08–1.22). Relative to uniparous women, the adjusted odds ratio for women with three births was 1.33 (95% CI=1.10–1.61) and for women with five or more births the OR was 1.62 (95% CI=1.18–2.23) (Table 2). The positive association with parity was similar in women older at diagnosis (age ⩾50 years) and in those younger at diagnosis (<50 years) (data not shown). When age at first birth was analysed as a continuous variable, there was a slight decrease in risk with increasing age at first delivery. After controlling for parity among parous women, the risk decreased by 8% for each 5-year increment of delay of first birth (OR=0.92; 95% CI=0.86–1.00) (Table 2).
Table 3 shows the risk of developing RCC by years since most recent birth among uniparous, biparous, triparous and ever-parous women relative to nulliparous women. Except for women with one live birth, risk estimates were consistently and often significantly elevated in all time periods since delivery.
Discussion
The influence of number of births on the risk of RCC remains unclear with a majority of studies finding no clear relation (Wynder et al, 1974; McLaughlin et al, 1984, 1992; Cantor et al, 1993; La Vecchia et al, 1993; Mellemgaard et al, 1994; Gago-Dominguez et al, 1999), while some investigators have reported positive associations (Kreiger et al, 1993; Chow et al, 1995; Lindblad et al, 1995).
Our results indicate that women with a history of high parity are at an increased risk of renal cell cancer. Compared to nulliparous women, the risk was nearly two times higher among women with five or more live births. This finding is in agreement with that of a large international multi-centre case–control study that found an 80% increased risk among high parity women. However, in that study there was no regular trend with increasing parity. In the same study, age at first birth was not associated with RCC risk after adjustment for age, study centre, body mass index and number of births (Lindblad et al, 1995). Compared to women with one or two births, multiparous women showed a more than two-fold risk increase, an association that was stronger among hypertensive or overweight women (Chow et al, 1995). In another study, a risk increase of similar magnitude was reported in multiparous women compared to nulliparous women, which was strictly limited to women with a previous history of foetal loss; among women with no foetal loss, the number of live births was unrelated to the risk of RCC (Kreiger et al, 1993). The latter study, as in our own, showed evidence of an inverse association between age at first birth and the risk of RCC.
The main strengths of the present study were its large size and the population-based design that minimised selection and information biases. By using nation-wide registry information, we were able to ascertain virtually all incident cases of RCC. The primary weakness was the absence of information on potential confounders such as Body Mass Index (BMI), weight cycling, hypertension, and smoking habits. Furthermore, in our assessment, pregnancy histories on complications or outcomes such as spontaneous and induced abortions were not available.
Of particular concern was the influence on our risk estimates by uncontrolled confounding by BMI. Childbearing is associated with a considerable increase in weight, usually followed by some degree of permanent weight-retention after delivery and lactation (Rössner, 1997). Results from a meta-analysis of 14 studies on obesity and the risk of RCC in women, indicate that the risk increases by 7% for each unit increase in BMI (Bergstrom et al, 2001).
Thus, pregnancy-associated weight gain may have influenced the observed relation to parity. To indirectly assess the relative importance of parity and BMI, we obtained data from the Swedish Medical Birth Register, a population-based database that since 1992 records pre-pregnancy weight among expecting mothers. These data showed that pre-pregnancy BMI increased by an average of 3.3 units between a first and sixth pregnancy (Table 4), producing an expected risk increase for RCC equalling 25.0% (1.073.3). In the present study, we found an estimated risk increase of 62% for women of parity 5+, relative to uniparous women. Taken together, these data provide evidence of an independent risk-modifying effect of parity on the risk of developing RCC, over and beyond the influence of BMI. This assumption is supported by the findings of the collaborative international study on renal cell cancer, where neither adjustment for smoking nor body mass index altered the estimates for parity (Lindblad et al, 1995). Chow et al (1995) reported an interaction between parity, obesity and the risk of RCC. In that study, the positive association with number of births was present in women with normal weight, but was stronger among obese subjects.
We can only speculate about the biological mechanisms whereby childbearing could affect renal carcinogenesis. Pregnancy-associated hormonal changes, particularly high oestrogen levels, may act as promotors of malignant change by stimulating renal cell proliferation either directly or via paracrine growth factors (Concolino et al, 1993). Both oestrogen and progesterone receptors are present in normal and malignant renal cells (Ronchi et al, 1984). High doses of potent oestrogens have been shown to induce renal cell tumours in laboratory rodents (Li and Li, 1990). The proliferative effect of oestrogen on kidney tissue seen experimentally may be mediated through the up-regulation of IGF-I receptors (Chen et al, 1996). Also, both insulin and IGF-I might contribute to the growth and proliferation of renal cell cancer. Experimentally evidence indicates that such growth factors and their receptors play a role in several renal diseases, including renal tumours (Zumkeller and Schofield, 1992; Stadler and Vogelzang, 1993; Kellerer et al, 1995). The consistent finding that obesity is a risk factor for human renal cell cancer, and the knowledge that obesity may lead to a hyperestrogenic environment and increased levels of insulin and insulin-like growth factor (IGF-1) (Azziz, 1989; Frystyk et al, 1995), provides indirect support that hormonal factors may play a role in human renal carcinogenesis. Also, epidemiological studies indicate that patients with diabetes have an increased risk of renal cell cancer (Schlehofer et al, 1996; Lindblad et al, 1999). In addition, a normal pregnancy is associated with hyperfiltration (Krutzen et al, 1992; Sturgiss et al, 1996). Animal studies suggest that glomerular hyperfiltration could play a role in the development of glomerulosclerosis, (Neuringer and Brenner, 1992; Westenend et al, 1992), which makes the nephrons more vulnerable for exposure to carcinogens.
The results of the present study are interesting because of both the highly regular trend between increasing parity and the risk of RCC, and the strength of the associations. Our observations appear unlikely to be fully explained by uncontrolled confounding and warrant further evaluation in large studies where detailed information on other risk factors for RCC and possible confounders also can be considered.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adami HO, Signorello LB, Trichopoulos D (1998) Towards an understanding of breast cancer etiology. Semin Cancer Biol 8: 255–262
Asal NR, Geyer JR, Risser DR, Lee ET, Kadamani S, Cherng N (1988) Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect Prev 13: 263–279
Azziz R (1989) Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil Steril 52: 703–725
Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A (2001) Obesity and renal cell cancer – a quantitative review. Br J Cancer 85: 984–990
Breslow NE, Day NE (1980) Statistical Methods in Cancer Research. Vol 1 - The analysis of case-control studies Vol. 32: Lyon: IARC
Cantor KP, Lynch CF, Johnson D (1993) Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4: 505–511
Chen CW, Oberley TD, Roy D (1996) Inhibition of stilbene estrogen-induced cell proliferation of renal epithelial cells through the modulation of insulin-like growth factor-I receptor expression. Cancer Lett 105: 51–59
Chow WH, McLaughlin JK, Mandel JS, Blot WJ, Niwa S, Fraumeni Jr JF (1995) Reproductive factors and the risk of renal cell cancer among women. Int J Cancer 60: 321–324
Concolino G, Lubrano C, Ombres M, Santonati A, Flammia GP, Di Silverio F (1993) Acquired cystic kidney disease: the hormonal hypothesis. Urology 41: 170–175
Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0 IARC CancerBase No. 5 Lyon: IARC Press
Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H (1995) Free insulin-like growth factors in human obesity. Metabolism 44: 37–44
Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC (1999) Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev 8: 999–1003
Johansson L, Finnäs F (1983) Fertility of Swedish women born 1927–1960 Stockholm: Statistics Sweden
Kellerer M, von Eye Corleta H, Muhlhofer A, Capp E, Mosthaf L, Bock S, Petrides PE, Haring HU (1995) Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer 62: 501–507
Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA (1993) Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 4: 101–110
Krutzen E, Olofsson P, Back SE, Nilsson-Ehle P (1992) Glomerular filtration rate in pregnancy: a study in normal subjects and in patients with hypertension, preeclampsia and diabetes. Scand J Clin Lab Invest 52: 387–392
La Vecchia C, Negri E, Franceschi S, Parazzini F (1993) Long-term impact of reproductive factors on cancer risk. Int J Cancer 53: 215–219
Li JJ, Li SA (1990) Estrogen carcinogenesis in hamster tissues: a critical review. Endocr Rev 11: 524–531
Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, McLaughlin JK, Nyren O, Adami HO (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42: 107–112
Lindblad P, Mellemgaard A, Schlehofer B, Adami HO, McCredie M, McLaughlin JK, Mandel JS (1995) International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 61: 192–198
McCredie M, Stewart JH (1992) Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 3: 323–331
McLaughlin JK, Gao YT, Gao RN, Zheng W, Ji BT, Blot WJ, Fraumeni Jr JF (1992) Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer 52: 562–565
McLaughlin JK, Lipworth L (2000) Epidemiologic aspects of renal cell cancer. Semin Oncol 27: 115–123
McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni Jr JF (1984) A population–based case–control study of renal cell carcinoma. J Natl Cancer Inst 72: 275–284
Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH (1994) Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int J Cancer 56: 66–71
Neuringer JR, Brenner BM (1992) Glomerular hypertension: cause and consequence of renal injury. J Hypertens Suppl 10: S91–S97
Ronchi E, Pizzocaro G, Miodini P, Piva L, Salvioni R, Di Fronzo G (1984) Steroid hormone receptors in normal and malignant human renal tissue: relationship with progestin therapy. J Steroid Biochem 21: 329–335
Rothman KJ, Greenland S (1998) Case–control studies. In Modern epidemiology pp 95 Philadelphia: Lippincott - Raven
Rössner S (1997) Weight gain in pregnancy. Hum Reprod 12: Suppl 1 110–115
Schlehofer B, Pommer W, Mellemgaard A, Stewart JH, McCredie M, Niwa S, Lindblad P, Mandel JS, McLaughlin JK, Wahrendorf J (1996) International renal-cell-cancer study. VI. the role of medical and family history. Int J Cancer 66: 723–726
Stadler W, Vogelzang NJ (1993) Human renal cancer carcinogenesis: a review of recent advances. Ann Oncol 4: 451–462
Sturgiss SN, Wilkinson R, Davison JM (1996) Renal reserve during human pregnancy. Am J Physiol 271: F16–F20
Swedish Cancer Registry (2000) Cancer Incidence in Sweden 1998 Stockholm: Socialstyrelsen
Westenend PJ, Nooyen YA, van der Krogt JA, van Brummelen P, Weening JJ (1992) Functional and structural determinants of glomerulosclerosis in the fawn-hooded rat. Eur J Clin Invest 22: 391–395
Wynder EL, Mabuchi K, Whitmore Jr WF (1974) Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst 53: 1619–1634
Zumkeller W, Schofield PN (1992) The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch B Cell Pathol Incl Mol Pathol 62: 207–220
Acknowledgements
We thank Dr Petra Otterblad-Olausson for kindly providing data from the Swedish Medical Birth Register. Supported by grants from the Swedish Cancer Society and the Swedish Society of Medicine. Rachel Remler was supported in part by National Institutes of Health, National Research Service Award 5 T32 ES07262 from the National Institute of Environmental Health Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Lambe, M., Lindblad, P., Wuu, J. et al. Pregnancy and risk of renal cell cancer: a population-based study in Sweden. Br J Cancer 86, 1425–1429 (2002). https://doi.org/10.1038/sj.bjc.6600263
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600263
Keywords
This article is cited by
-
Renal cell cancer among African Americans: an epidemiologic review
BMC Cancer (2011)
-
A case–control study of reproductive factors and renal cell carcinoma among black and white women in the United States
Cancer Causes & Control (2011)
-
Nierentumore in der Schwangerschaft
Der Urologe (2011)
-
Management of urological cancers during pregnancy
Nature Reviews Urology (2010)
-
Epidemiology and risk factors for kidney cancer
Nature Reviews Urology (2010)